SEC Form 4 · accession 0001235802-17-000051
ENTELLUS MEDICAL INC · ENTL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brent Moen
Officer — CFO and Secretary
Period of report
May 8, 2017
Accepted (ET)
May 8, 2017 · 6:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374128
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1 | May 8, 2017 | P | 6,100 | $12.2091 | A | 13,600 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 7,500 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan.